Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Short term Debt (2024 - 2025)

Basel Medical (BMGL) posted Short term Debt of $887764.0 for Q4 2025, down 45.52% sequentially from $1.6 million in Q2 2025, and up 81.44% YoY from $489275.0 in Q4 2024.

Analysis

Basel Medical (BMGL) Short term Debt (2024 - 2025) Analysis & Trends

Basel Medical has reported Short term Debt for 2 years, with the latest figure at $887764.0 in Q4 2025.

  • Quarterly Short term Debt rose 81.44% year-over-year to $887764.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $887764.0 (up 81.44% YoY) and the FY2025 annual result came in at $1.5 million, up 10.59% from the prior year.
  • Short term Debt declined to $887764.0 in Q4 2025 per BMGL's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Short term Debt peaked at $2.0 million in Q2 2024 and troughed at $489275.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.42 Bn 88.41 Bn 15.19 Bn
2 Tenet Healthcare 22.09 Bn 19.92 Bn 4.45 Bn
3 Encompass Health 12.09 Bn 11.96 Bn 1.34 Bn
4 Davita 11.86 Bn 11.17 Bn 1.16 Bn
5 Universal Health Services 10.16 Bn 10.02 Bn 3.29 Bn
6 Ensign 9.92 Bn 9.60 Bn 306.24 Mn
7 Chemed 6.90 Bn 6.86 Bn 221.47 Mn
8 Pacs 6.75 Bn 6.58 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.27 Mn
Jun 30, 2025 1.63 Mn
Dec 31, 2024 4.37 Mn
Jun 30, 2024 2.00 Mn